DexCom's recent licensing deal with Nanowear is likely to reinforce the broader potential of CGMs in continuous metabolic ...

Per the terms of the agreement, Nanowear will use glucose data from Dexcom G7 Continuous Glucose Monitoring Systems (CGM) synchronously alongside Nanowear’s previously FDA-cleared cardiovascular ...

Eligible residents living with diabetes in Saskatchewan who rely on any type of insulin may be eligible to receive coverage ...

As part of the provincial government’s recent Budget 2025 announcement, Dexcom G7 and Dexcom G6 CGM systems are now publicly covered for residents living with diabetes age 18-25 and those over ...

The government of Saskatchewan has expanded public coverage for continuous glucose monitoring (CGM) systems. The expansion, which now provides full coverage for CGMs for young adults ages 18 to 25 and ...

Meanwhile, the UK launch of Freestyle Libre 3 comes as rival real-time CGM player Dexcom received a European CE mark for its G7 device for people with diabetes aged two years and older.

Both companies also sell reimbursable prescription CGMs for type 1 and type 2 diabetes, respectively, the G7 and Libre 3 range ... annual growth rates (CAGR) of CGM devices for insulin-dependent ...